What is the next appropriate treatment for patients whose chronic lymphocytic leukemia (CLL) comes back after using a targeted therapy? Watch now to hear CLL expert Dr. Nitin Jain, from The University of Texas MD Anderson Cancer Center, discuss suitable agents for relapsed CLL patients.

Published by Patient Power – 23 July 2019

How can chronic lymphocytic leukemia (CLL) patients choose the right provider? Why is it important to see a specialist? Patient advocates James Miller and Carol Preston share advice for others seeking a knowledgeable, confidence-building healthcare team to treat their CLL. Watch now to learn more.

Published by Patient Power – 25 July 2019

The afternoon portion of our recent chronic lymphocytic leukemia (CLL) Town Meeting in Cincinnati, Ohio features CLL patients John Binz and Dave Kasanicky and care partner Lynnda Kasanicky discussing the impact of living and raising a family with a chronic cancer.

Dr Amy Holmes provides an accessible overview of Chronic Lymphocytic Leukaemia (CLL) to mark World CLL Day, focusing on helping patients, families, and the wider community understand the condition and current approaches to care.

What new therapies are in the pipeline for chronic lymphocytic leukemia (CLL)? What is the side effect profile for novel agents?

What are the latest international and local developments in CLL research and treatment, and what’s on the horizon? What is the optimal approach to ‘watch and wait’ management? How can we access clinical trials? How does New Zealand compare with international standards of care?